Evaluation of Adjuvant! Online to predict the effect of optimal endocrine therapy
http://www.abstract.asco.org/AbstView_65_31886.html
"Conclusions: AOL appears to underestimate the effectiveness of adjuvant endocrine therapy alone for premenopausal women with endocrine responsive breast cancer, thus overestimating the added benefit - if any - from chemotherapy for this patient population. Prospective clinical trials addressing the question are warranted." Hopeful |
All times are GMT -7. The time now is 06:32 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021